When a doctor requests treatment for a patient in an out-of-reach country, my job is to ensure medicine gets to that patient. Multiply this by 30,000 patients across 70+ countries, and our supply chain becomes a complex system of forecasting demand, requesting donations, shipping medicines, tracking product and confirming deliveries at each destination.
I recently spoke at the ReConnect 2021 conference, along with my colleague Michael Wrigglesworth, Senior Director of Program Strategy and Data Solutions, about how The Max Foundation connects supply chain and technology. It was an opportunity to share how our unique patient-centric model is supported by our supply chain activities that increase global access to treatment.
The two-day event featured speakers from diverse organizations, including other NGOs, such as VillageReach discussing drone delivery of medicines, and industry, such as logistics provider Expeditors International. Our presentation was entitled “Medicine Distribution in Low- and Middle-Income Countries: Technologies and Supply Chains” and was moderated by Dr. Surya Pathak, professor at the University of Washington School of Business.
The well-organized conference enabled us to provide some practical examples of how our Patient Access Tracking System is enhancing processes to make our supply chain more data-driven. Through interconnected technology, we’re able to successfully track stocks of medicine and forecast for future deliveries, all to get medicine into the hands of those in need. Particularly over the past 18 months of the global pandemic, we have remained resolute in our commitment to maximize our impact through innovation and collaboration.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Radha Bai Chandra is a 62-year-old widow, a mother, and the longest-surviving beneficiary of Max’s programs in Fiji. Although her search for treatment was long and challenging, the second life she now has from that search is worth it. In 2005, Radha Bai noted a change in her energy levels. She was usually an active….
Un Paso Max, meaning “Un Paso Mas” (One More Step) is a fitting name for a group led by cancer survivors who are willing to take an extra step to help others. Un Paso Max is the name of the CML and GIST patient association in the Dominican Republic. One can trace the origins of this group to a small meeting in 2008. It only took a bit of encouragement and support on the part of The Max Foundation to unlock the passion of a handful of courageous survivors in Santo Domingo, and the seed of a patient association was planted.
Bunthan Kahn was diagnosed with chronic myeloid leukemia (CML) in 2017. He’s a tour guide, a husband, a young father, and an avid learner. From traveling far to meet with specialized physicians, to seeking treatment in his country, his journey toward finding hope took perseverance.
